GLP-1 Drugs May Lower Diabetes, Heart Risks vs. Standard Prevention
DALLAS, Nov. 2, 2026 — GLP-1 (glucagon-like peptide-1 receptor agonists) medications, currently popular for weight-loss, may help prevent Type 2 diabetes and lower the risk of…
MH
By Maren Holt · Senior Reporter, GLP-1
Nov 2 05:40 ETSource: Mirage News
From the source
Read at miragenews.comGLP-1 Drugs May Lower Diabetes, Heart Risks vs. Standard Prevention
DALLAS, Nov. 2, 2026 — GLP-1 (glucagon-like peptide-1 receptor agonists) medications, currently popular for weight-loss, may help prevent Type 2 diabetes and lower the risk of heart attack and stroke more than the standard diabetes prevention medication metformin among people with prediabetes, according to new, independent, preliminary research presented at the American Heart Association's Scienti
